224 related articles for article (PubMed ID: 12235823)
1. [A study on pathomechanisms of paraneoplastic neurological syndrome].
Tanaka K
Rinsho Shinkeigaku; 2001 Dec; 41(12):1150-2. PubMed ID: 12235823
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of paraneoplastic neurological syndromes].
Tanaka K
Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
[TBL] [Abstract][Full Text] [Related]
3. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Idezuka J; Tsuji S
Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
[TBL] [Abstract][Full Text] [Related]
4. [A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody].
Tanaka M; Tanaka K
Rinsho Shinkeigaku; 1999 Jun; 39(6):603-5. PubMed ID: 10502981
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of antineuronal autoantibodies in a series of neurological patients.
Vianello M; Vitaliani R; Pezzani R; Nicolao P; Betterle C; Keir G; Thompson EJ; Tavolato B; Scaravilli F; Giometto B
J Neurol Sci; 2004 May; 220(1-2):29-36. PubMed ID: 15140602
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic motor neuron disease].
Sakakibara R
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):355-9. PubMed ID: 11031968
[No Abstract] [Full Text] [Related]
7. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
8. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
9. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
King PH; Redden D; Palmgren JS; Nabors LB; Lennon VA
J Autoimmun; 1999 Dec; 13(4):435-43. PubMed ID: 10585760
[TBL] [Abstract][Full Text] [Related]
10. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
Dropcho EJ; King PH
Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic neurological autoimmune diseases].
Voltz R
Dtsch Med Wochenschr; 2004 Aug; 129(33):1743-6. PubMed ID: 15295685
[No Abstract] [Full Text] [Related]
13. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
14. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
[TBL] [Abstract][Full Text] [Related]
15. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
[TBL] [Abstract][Full Text] [Related]
16. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
de Beukelaar JW; Verjans GM; van Norden Y; Milikan JC; Kraan J; Hooijkaas H; Sintnicolaas K; Gratama JW; Sillevis Smitt PA
Cancer Immunol Immunother; 2007 Sep; 56(9):1501-6. PubMed ID: 17597332
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum.
Storstein A; Monstad SE; Honnorat J; Vedeler CA
J Neuroimmunol; 2004 Oct; 155(1-2):150-4. PubMed ID: 15342206
[TBL] [Abstract][Full Text] [Related]
18. [Paraneoplastic encephalomyelitis/sensory neuropathy].
Tanaka M; Tanaka K
Ryoikibetsu Shokogun Shirizu; 2000; (31):68-72. PubMed ID: 11269191
[No Abstract] [Full Text] [Related]
19. Anti-Hu antibody neuropathy: a clinical, electrophysiological, and pathological study.
Oh SJ; Gürtekin Y; Dropcho EJ; King P; Claussen GC
Clin Neurophysiol; 2005 Jan; 116(1):28-34. PubMed ID: 15589180
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
